Published in:
01-02-2004 | Poster presentation
Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
Authors:
D Thabut, R de Franchis, F Bendtsen, G D'Amico, A Albillos, JG Abraldes, S Sofelt, J Bosch, the European Study Group on rFVIIa in UGI hemorrhage
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
Upper gastrointestinal bleeding (UGIB) is a severe and frequent complication of cirrhosis. Preliminary results show that rFVIIa may reduce bleeding in cirrhotic patients. This trial aimed to determine the efficacy and safety of rFVIIa in cirrhotic patients with variceal and nonvariceal UGIB. …